Clearly, our data does not prove that anti-inflammatory approaches to treating obesity-associated insulin resistance will not be useful and we are aware of several mouse studies in which knockdown or inhibition of inflammatory signalling intermediates were shown to improve insulin sensitivity34, 35. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.